J B Chemical receives USFDA approval for Venlafaxine Extended Release Tablets

7 Dec 2022 , 01:35 AM

J B Chemicals Pharmaceuticals has received ANDA approval from the USFDA for Venlafaxine Extended Release Tablets 375mg 75mg 150mg and 225mg This product is based on OROS Osmotic Controlled Release Oral Delivery System technology an advanced and precision-controlled release mechanism The generic product approval is bioequivalent and therapeutically equivalent to the reference listed drug RLD Venlafaxine Hydrochloride Extended-Release Tablets 375 mg 75 mg 150 mg and 225 mg of Osmotica Pharmaceutical US LLC As per IQVIA Health MAT Oct 2022 data Venlafaxine Extended-Release tablets recorded annualized sales of approximately $ 48 million in the US